Biospecimens Core

Empowering Your Research

 

The CCTS Biospecimen Core facilitates access to biological specimens, provides responsive biobanking services, and trains investigators in biospecimen-related research. 

Researcher's hand pulling test tube
Illustration of a COVID-19 particle

The CCTS COVID-19 Biobank will initially be collecting specimens from inpatients who have tested positive or are showing signs consistent with COVID-19.

Request specimens from the bank through the CCTS Service Request Formselect "Biospecimens" and then select "COVID19 Biobank".

Learn more. »


The University of Kentucky Research Registry and Specimen Bank currently includes more than 34,339 patients who've consented to participate, with the following specimens available:

 

  • ​​​Buffy Coat: 1,148 samples 

  • CSF: 84 samples

  • Fat: 217 samples 

  • Muscle: 27 samples

  • Arterial Plaque (fixed): 17 samples

  • Plasma: 1,448 samples

  • Red Blood: 698 samples 

  • Serum: 1,610 samples

  • Tissues: 539 samples
    Including lung, stomach, liver, large and small intestine, aortic tissue, and spleen

        *Last updated Oct 21, 2019

 

We can also work with you to obtain other types specimens needed for your research.

 

Request Biospecimen Services »  

 


Learn more about CCTS and UK biospecimen resources: 

 

CCTS Biobank FAQs

 

 

 

 

 


 

How to Use i2b2 to Search for Biospecimen Availability

 

 

 

 


 

Additional Biospecimen Resources at UK

 

 

 

 

 


 

CCTS Biobank Impact

35,227

Enrolled Biobank Patients

83.9%

Consent Rate for Biobank Enrollment

3,000

Biospecimen Samples Dispersed

In the News

  • LEX18 Covid-19 Blood Clot Story
    • Oct 16 2020

    The research, supported by a COVID-19 pilot grant from the CCTS, suggests lung damage caused by COVID-19 might be to blame for prolonged clot risk.

  • Behind the Blue logo
    • Oct 13 2020

    Dr. Lisa Cassis, UK’s vice president for research, oversees the university’s vast medical and nonmedical research efforts. On this episode of "Behind the Blue," she discusses the many areas UK's Office of Research is prioritizing, including greater diversity and inclusion, the increasing commitment to opportunities for undergraduate research, returning research efforts to higher capacity during the COVID-19 pandemic, and more.

  • UK researcher Jeremy Wood, pictured in his lab wearing a white coat, is co-leading research that may provide answers for why so many COVID-19 patients experience blood clotting.
    • Sep 17 2020

    The study suggests that localized inflammation in the lungs caused by COVID-19 may be responsible for the increased presence of blood clots in patients, and that the risk of thrombosis could persist after the infection clears.